Company Updates
Interested in the newest medical platform that will deliver diagnostics that are non-invasive, faster and less expensive than current methods? Maybe want to follow the ups and challenges of a startup as we journey to FDA approval? Join our adventure!
LinkedIn Posts
June 10, 2024
CARY, NORTH CAROLINA, UNITED STATES, June 10, 2024 -- EMF Disturbance Monitors, Inc., a groundbreaking startup based in Cary, North Carolina, has been awarded an "Incentive” grant by the One North Carolina Small Business Program.
Novel Medical Device/Platform to Quickly Diagnose Congestive Heart Failure
/EINPresswire.com/ --EMF Disturbance Monitors, Inc., a groundbreaking startup based in Cary, North Carolina, has been awarded an "Incentive” grant by the One North Carolina Small Business Program. Financial terms of the grant were not disclosed.
“Our mission is to enable the diagnosis of Congestive Heart Failure faster than any current method,” said Les Hamashima, CEO of EMF Disturbance Monitors. “The financial support is critical and equally important is having the encouragement from the State of North Carolina as we intend to continue our growth in our home state.”
April 30, 2024
EMF Disturbance Monitors, Inc. successfully completes an animal safety trail at the University of North Carolina
EMF Disturbance Monitors, Inc. successfully completed an animal safety trial for the cardiac application of our patented technology on 4/30/24. This novel technology which is designed to measure the electromagnetic energy output of the heart was tested on Rhesus macaque monkeys.
The test animals wore a prototype of our 3-dimensional sensor array vest and were tested in a variety of low-frequency electromagnetic fields for 30-45 minutes. The test animals did not experience any Adverse Events from testing and were returned safely to their colony later that day.
Data analysis from the study confirms that this new, patented technology significantly magnifies the electromagnetic energy emissions making it possible to estimate the actual amount of energy each animal’s heart produces.
January 19, 2024
Morehead Cain internships to be sponsored by EMF Disturbance Monitors, Inc.
The Morehead Cain Foundation at the University of North Carolina at Chapel Hill has partnered with EMF Disturbance Monitors, Inc. to sponsor a series of undergraduate student internships during 2024-2025. The prestigious Morehead Cain scholarship provides tuition, fees and expenses to outstanding high school students from North Carolina and selected schools from the United States, Canada and the UK. After a competitive interview process, four scholars have been chosen to participate in our planned animal safety trial and human volunteer trials. The scholars with work with the UNC faculty to assess the safety and efficacy of the cardiac application of our patented medical diagnostic platform
https://www.moreheadcain.org
November 16, 2023
EMF Disturbance Monitors, Inc. presents at CED Demo Day event in Raleigh, N.C.
EMF Disturbance Monitors, Inc. was one of six start-up companies in the GRO incubator program chosen to present at Demo Day. The event at the Red Hat Tower in Raleigh, N.C. was attended by successful entrepreneurs, media, venture capital companies and business services companies.
https://grepbeat.com/2023/11/17/six-startups-present-their-pitches-at-ced-led-gro-incubator-demo-day/
October 27, 2023
EMF Disturbance Monitors, Inc. applies for FDA approval in the United States
EMF Disturbance Monitors, Inc. has begun the process to obtain FDA approval in the U.S.A. for their innovative diagnostic platform. The process is expected to take several years as the company submits information from clinical trials studying the safety and efficacy of a cardiac application of their technology.
https://www.fda.gov/medical-devices
September 25, 2023
EMF Disturbance Monitors, Inc. Signs Agreement with UNC Chapel Hill for Clinical Trials
EMF Disturbance Monitors, Inc. has signed a collaboration agreement with the University of North Carolina at Chapel Hill for animal and human safety trials of a cardiac application of its patented technology. Studies on non-human primates will begin in January, 2024 at the Small Animal Imaging Research facility headed by Dr. Hong Yuan. This is a major and necessary step toward FDA approval.
August 22, 2023
EMF Disturbance Monitors chosen for RTP Start-up incubator
EMF Disturbance Monitors, Inc. has been chosen as one of eight finalists for the prestigious GRO Incubator program sponsored by the Council for Entrepreneurial Development (CED). CED is a non-profit organized in 1984 to promote new businesses in the Research Triangle Park area of North Carolina. EMF has been enrolled in an accelerated 12 week program for promising star-up businesses.
https://cednc.org/blog/gro6-ceds-incubator-is-gro-ing-eight-new-companies/.